- Trials with a EudraCT protocol (5)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
5 result(s) found for: Eating Disorder Inventory.
Displaying page 1 of 1.
EudraCT Number: 2019-004054-28 | Sponsor Protocol Number: Panorexia | Start Date*: 2020-06-23 | ||||||||||||||||
Sponsor Name:Imperial College London | ||||||||||||||||||
Full Title: Psilocybin as a Treatment for Anorexia Nervosa: A Pilot Study | ||||||||||||||||||
Medical condition: Anorexia Nervosa | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-003310-14 | Sponsor Protocol Number: SPD489-344 | Start Date*: 2013-06-18 |
Sponsor Name:Shire Development LLC | ||
Full Title: The SPD489-344, Phase 3, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Dose-optimization Study to Evaluate the Efficacy, Safety, and Tolerability of SPD489 in Adults Ag... | ||
Medical condition: Binge eating disorder is characterized by recurrent, distressing episodes of uncontrolled consumption of large amounts of food (binge eating) without the inappropriate compensatory weight loss beha... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Prematurely Ended) IT (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2012-003309-91 | Sponsor Protocol Number: SPD489-343 | Start Date*: 2013-03-20 |
Sponsor Name:Shire Development, LLC | ||
Full Title: The SPD489-343, Phase 3, Multicenter, Randomized, Double-blind, Parallel-group, Placebo-controlled, Dose-optimization Study to Evaluate the Efficacy, Safety, and Tolerability of SPD489 in Adults Ag... | ||
Medical condition: Binge eating disorder is characterized by recurrent, distressing episodes of uncontrolled consumption of large amounts of food (binge eating) without the inappropriate compensatory weight loss beha... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Completed) DE (Completed) ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2022-000696-39 | Sponsor Protocol Number: HNF1595-21 | Start Date*: 2023-02-21 |
Sponsor Name:Helse-Nord | ||
Full Title: Estrogen replacement therapy (ERT) for treatment of adolescent anorexia nervosa – An open label study | ||
Medical condition: Anorexia nervosa | ||
Disease: | ||
Population Age: Adolescents, Under 18 | Gender: Female | |
Trial protocol: NO (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2007-005631-29 | Sponsor Protocol Number: 24420221 | Start Date*: 2008-06-18 | |||||||||||
Sponsor Name:Center for Spiseforstyrrelse, Endokrinologisk Afdeling M, Odense Universitetshospital | |||||||||||||
Full Title: Cannabinoid CB1 receptor agonist treatment in severe chronic anorexia nervosa | |||||||||||||
Medical condition: severe chronic Anorexia Nervosa | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
